Patient Opportunity FI (LMOFX)

Fund Assets	2.07B
Expense Ratio	1.739%
Min. Investment	$1,000
Turnover	27.00%
Dividend (ttm)	n/a
Dividend Yield	n/a
Dividend Growth	n/a
Payout Frequency	n/a
Ex-Dividend Date	n/a

Previous Close	57.43
YTD Return	12.73%
1-Year Return	21.29%
5-Year Return	45.90%
52-Week Low	44.94
52-Week High	59.69
Beta (5Y)	1.95
Holdings	38
Inception Date	Feb 13, 2004

About LMOFX

Patient Opportunity Trust Class FI is an actively managed mutual fund focused on long-term capital growth through a value-oriented, contrarian investment approach. Managed by Patient Capital Management, the fund seeks to identify and invest in 30 to 50 companies that are believed to be significantly undervalued across various industries, sectors, and market capitalizations. Its strategy emphasizes flexibility, allowing investment in both domestic and select foreign equities, with approximately 87% of assets allocated to U.S. stocks and around 10% in foreign holdings. The fund distinguishes itself with a high active share—typically above 95%—making it a potential diversifier in a broad equity portfolio and offering differentiation from the S&P 500 benchmark. Led by an experienced management team, including Samantha McLemore, CFA, the fund’s concentrated portfolio and willingness to depart from mainstream investment trends can result in above-average volatility, but also offers the potential for significant long-term outperformance through market cycles. Since its inception in 2004, Patient Opportunity Trust Class FI has aimed to deliver disciplined, opportunistic value investing for investors seeking an alternative to conventional equity funds.

• Fund Family: Patient Capital Management
• Category: Mid-Cap Value
• Performance Rating: Below Average
• Risk Rating: High
• Stock Exchange: Nasdaq
• Ticker Symbol: LMOFX
• Share Class: Class Fi
• Index: S&P 500 TR

Performance

LMOFX had a total return of 21.29% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.99%.

Equivalent Funds

These are funds that follow the same index from the other major fund companies.

Symbol	Provider	Name	Expense Ratio
FIQCX	Fidelity	Fidelity Advisor Asset Manager 85% Z	0.56%
FBRNX	Fidelity	Fidelity Advisor Stock Sel I	0.53%
FSSKX	Fidelity	Fidelity Stock Selec-Class K	0.42%
FSJHX	Fidelity	Fidelity Advisor Stock Sel M	1.07%
FEYAX	Fidelity	Fidelity Advisor Asset Manager 85% A	0.92%

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
MVISX	Class Is	1.33%
LMNOX	Class I	1.39%
LGOAX	Class A	1.69%
LMORX	Class R	1.94%

Top 10 Holdings

54.84% of assets

Name	Symbol	Weight
Royalty Pharma plc	RPRX	6.98%
Citigroup Inc.	C	6.97%
Alphabet Inc.	GOOGL	6.67%
UnitedHealth Group Incorporated	UNH	6.21%
Amazon.com, Inc.	AMZN	5.64%
NVIDIA Corporation	NVDA	4.98%
CVS Health Corporation	CVS	4.51%
QXO, Inc.	QXO	4.48%
Norwegian Cruise Line Holdings Ltd.	NCLH	4.21%
Precigen Warrant Restricted	n/a	4.19%

Data Sources: Tiingo, Twelve Data, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Oct 16, 2026

Data Sources Report a data error